Accenture (NYSE: ACN) has made an investment through Accenture Ventures in Within, an AI platform company designed to help organizations map, enhance, and automate business processes. The partnership aims to assist clients in gaining deeper insights into operational workflows to deploy AI agents effectively.

This move addresses a critical gap identified in Accenture’s latest Pulse of Change survey. While 82% of C-suite leaders are increasing AI investment, only 23% report achieving widespread, sustained business value from the technology. This figure is down from 32% earlier this year, highlighting a significant disconnect between spending and outcomes.

Bridging the context gap

A primary reason for the low value realization is that day-to-day operations, including exceptions and workarounds, are rarely documented. Consequently, AI systems often lack the necessary context to understand requirements. Within’s platform captures how employees work across applications and tracks undocumented offline interactions, compiling this data into a continuously updated context layer called the Work Brain.

Jason Dess, Accenture’s Industry and Process Reinvention Lead, noted that organizations often lack a clear picture of their starting point. "Without that understanding, it’s difficult to scale AI beyond isolated use cases," Dess said. He added that Within helps create this operational picture quickly, accelerating transformation programs and shortening delivery timelines.

Partnership scope and capabilities

The collaboration combines Accenture’s scale in AI delivery and industry expertise with Within’s work-to-agent platform. The goal is to help clients accelerate their path from process discovery to agent deployment. The platform supports various functions, including finance, HR, sales, marketing, customer service, IT, supply chain, procurement, and commercial operations.

Within is built on a private, sovereign architecture designed for data privacy and security, making it suitable for regulated industries. It also accelerates ERP and operating model transformation programs, which traditionally require significant time and resources.

Key metrics from Accenture survey

What the numbers show

The divergence between investment intent and realized value is stark. With 82% of leaders boosting AI spend but only 23% seeing sustained value, there is a 59 percentage point gap between commitment and outcome. The drop in value realization from 32% to 23% suggests that simply increasing capital allocation is insufficient without addressing foundational process visibility.

Florida Representative Scott Franklin purchased shares in Accenture (NYSE: ACN) and McDonald's (NYSE: MCD) on August 26, 2026. The congressional disclosure filed on September 17, 2026, lists the transaction values between $1,001 and $15,000 for each position.

The filings also reveal purchases in Novo Nordisk (NYSE: NVO) and Lord Abbett Short Duration High fund (LSYIX) on the same date. These transactions are part of Franklin's broader trading activity, which includes 180 trades totaling over $5.05 million over the past three years.

Recent Trading Activity

Franklin's recent portfolio adjustments include multiple purchases executed simultaneously. The disclosed transactions reflect a diversified approach across technology, consumer staples, and healthcare sectors.

Regulatory Context

Under the STOCK Act signed by President Barack Obama in April 2012, members of Congress must file Periodic Transaction Reports within 45 days of a transaction. The law prohibits using private information for personal gain and mandates monthly disclosures.

What the Numbers Show

Franklin executed five distinct purchase transactions on August 26, 2026, all falling within the $1,001 to $15,000 value bracket. The simultaneous acquisition of positions in both Accenture and McDonald's suggests a coordinated rebalancing rather than isolated trades, given the identical timing and value ranges disclosed.